The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar M1 – Inspired by STOPP/START: a new prescription screening tool for adult patients
Affiliation
Clinic of Genolier / University of Geneva / Cranfield University
Country
Switzerland
1. Current Status, Position
Pierre-Olivier Lang is associate director of the Nescens centre of preventive medicine at the Clinic of Genolier in Switzerland.
2. Education
Pierre-Olivier Lang is a specialist in internal medicine, prevention and public health, and in the medicine of aging. He is Privatdozent at University of Geneva and an Associate Professor in “Translational Medicine” at Cranfield University (UK).
3. Research Area
Pierre-Olivier Lang’s research activities focus on:
- Preventing drug-drug, drug-disease and drug related-adverse outcomes in the aging and aged adult populations. He has contributed to the validation, spreading and transcultural adaptation of the STOPP-START1 set of criteria. He participates to the development and validation of the STOPP-START2 set of criteria.
- The aging of the immune system, its diagnosis and its regeneration and its impact on vaccine response and vaccine effectiveness.
Conflict of interest: None